Dosing and Administration | BYDUREON BCise® (exenatide extended-release) injectable suspension 2 mg | For HCPs
![BYDUREON® Pen, a Treatment Option for Adults with Type 2 Diabetes, Now Available in Pharmacies | Business Wire BYDUREON® Pen, a Treatment Option for Adults with Type 2 Diabetes, Now Available in Pharmacies | Business Wire](https://mms.businesswire.com/media/20140908005269/en/430631/5/BYDUREON_Pen_image.jpg)
BYDUREON® Pen, a Treatment Option for Adults with Type 2 Diabetes, Now Available in Pharmacies | Business Wire
![Evaluation of the Dual-Chamber Pen Design for the Injection of Exenatide Once Weekly for the Treatment of Type 2 Diabetes - Susan LaRue, Jaret Malloy, 2015 Evaluation of the Dual-Chamber Pen Design for the Injection of Exenatide Once Weekly for the Treatment of Type 2 Diabetes - Susan LaRue, Jaret Malloy, 2015](https://journals.sagepub.com/cms/10.1177/1932296815576186/asset/images/large/10.1177_1932296815576186-fig2.jpeg)
Evaluation of the Dual-Chamber Pen Design for the Injection of Exenatide Once Weekly for the Treatment of Type 2 Diabetes - Susan LaRue, Jaret Malloy, 2015
![These highlights do not include all the information needed to use BYDUREON safely and effectively. See full prescribing information for BYDUREON. BYDUREON® (exenatide) for extended-release injectable suspension, for subcutaneous useInitial U.S. Approval: These highlights do not include all the information needed to use BYDUREON safely and effectively. See full prescribing information for BYDUREON. BYDUREON® (exenatide) for extended-release injectable suspension, for subcutaneous useInitial U.S. Approval:](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=image-01.jpg&id=683726)